Steen, V. D. & Medsger, T. A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 43, 2437–2444 (2000).
Richard, N. et al. Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology 58, 636–644 (2019).
Gyger, G. & Baron, M. Systemic sclerosis: gastrointestinal disease and its management. Rheum. Dis. Clin. North. Am. 41, 459–473 (2015).
Kaniecki, T., Abdi, T. & McMahan, Z. H. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis. Best Pract. Res. Clin. Rheumatol. 35, 101666 (2021).
Jaovisidha, K., Csuka, M. E., Almagro, U. A. & Soergel, K. H. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. Semin. Arthritis Rheum. 34, 689–702 (2005).
McMahan, Z. H. et al. Relationship between gastrointestinal transit, Medsger gastrointestinal severity, and University of California-Los Angeles scleroderma clinical trial consortium gastrointestinal tract 2.0 symptoms in patients with systemic sclerosis. Arthritis Care Res. 74, 442–450 (2022).
Kawaguchi, Y. et al. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann. Rheum. Dis. 68, 710–714 (2009).
Lock, G. et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J. Rheumatol. 25, 1330–1335 (1998).
Adler, B. L., Russell, J. W., Hummers, L. K. & McMahan, Z. H. Symptoms of autonomic dysfunction in systemic sclerosis assessed by the COMPASS-31 questionnaire. J. Rheumatol. 45, 1145–1152 (2018).
Furness, J. B., Callaghan, B. P., Rivera, L. R. & Cho, H. J. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv. Exp. Med. Biol. 817, 39–71 (2014).
Kulkarni, S. et al. Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and neurogenesis. Proc. Natl Acad. Sci. USA 114, E3709–E3718 (2017).
Kulkarni, S. et al. Advances in enteric neurobiology: the “brain” in the gut in health and disease. J. Neurosci. 38, 9346–9354 (2018).
Kulkarni, S. & Pasricha, P. J. Decoding the enteric nervous system: the beginning of our understanding of enteric neuromuscular disorders. Gastroenterology 160, 651–652 (2021).
McMahan, Z. H. et al. Anti-RNPC-3 (U11/U12) antibodies in systemic sclerosis in patients with moderate-to-severe gastrointestinal dysmotility. Arthritis Care Res. 71, 1164–1170 (2019).
McMahan, Z. H., Paik, J. J., Wigley, F. M. & Hummers, L. K. Determining the risk factors and clinical features associated with severe gastrointestinal dysmotility in systemic sclerosis. Arthritis Care Res. 70, 1385–1392 (2018).
Dein, E. et al. Evaluation of risk factors for pseudo-obstruction in systemic sclerosis. Semin. Arthritis Rheum. 49, 405–410 (2019).
Ziessman, H. A., Jeyasingam, M., Khan, A. U., McMahan, Z. & Pasricha, P. J. Experience with esophagogastrointestinal transit scintigraphy in the initial 229 patients: multiple regions of dysmotility are common. J. Nucl. Med. 62, 115–122 (2021).
Vigone, B. et al. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study. Arthritis Res. Ther. 19, 145 (2017).
Karamanolis, G. P. et al. The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial. Arthritis Res. Ther. 18, 195 (2016).
McMahan, Z. H. & Khanna, D. Managing gastrointestinal complications in patients with systemic sclerosis. Curr. Treat. Options Gastroenterol. 18, 531–544 (2020).
Rigamonti, C. et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55, 388–394 (2006).
Morrisroe, K. et al. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival. Arthritis Res. Ther. 24, 103 (2022).
Drokhlyansky, E. et al. The human and mouse enteric nervous system at single-cell resolution. Cell 182, 1606–1622.e1623 (2020).
Morarach, K. et al. Diversification of molecularly defined myenteric neuron classes revealed by single-cell RNA sequencing. Nat. Neurosci. 24, 34–46 (2021).
Jarret, A. et al. Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity. Cell 180, 813–814 (2020).
Muller, P. A. et al. Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. Cell 158, 300–313 (2014).
Nickerson, A. J., Rottgen, T. S. & Rajendran, V. M. Activation of KCNQ (KV7) K+ channels in enteric neurons inhibits epithelial Cl– secretion in mouse distal colon. Am. J. Physiol. Cell Physiol. 320, C1074–C1087 (2021).
Moreno, S. et al. Epithelial propionyl- and butyrylcholine as novel regulators of colonic ion transport. Br. J. Pharmacol. 173, 2766–2779 (2016).
Fung, C. & Vanden Berghe, P. Functional circuits and signal processing in the enteric nervous system. Cell Mol. Life Sci. 77, 4505–4522 (2020).
Phillips, R. J. & Powley, T. L. Innervation of the gastrointestinal tract: patterns of aging. Auton. Neurosci. 136, 1–19 (2007).
Kang, Y. N., Fung, C. & Vanden Berghe, P. Gut innervation and enteric nervous system development: a spatial, temporal and molecular tour de force. Development 148, dev182543 (2021).
Duan, H. et al. Regulation of the autonomic nervous system on intestine. Front. Physiol. 12, 700129 (2021).
Powley, T. L. Brain-gut communication: vagovagal reflexes interconnect the two “brains”. Am. J. Physiol. Gastrointest. Liver Physiol. 321, G576–G587 (2021).
Masliukov, P. M., Emanuilov, A. I. & Budnik, A. F. Sympathetic innervation of the development, maturity, and aging of the gastrointestinal tract. Anat. Rec. https://doi.org/10.1002/ar.25015 (2022).
Mercado-Perez, A. & Beyder, A. Gut feelings: mechanosensing in the gastrointestinal tract. Nat. Rev. Gastroenterol. Hepatol. 19, 283–296 (2022).
Spencer, N. J. & Hu, H. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat. Rev. Gastroenterol. Hepatol. 17, 338–351 (2020).
Kulkarni, S., Kurapati, S. & Bogunovic, M. Neuro-innate immune interactions in gut mucosal immunity. Curr. Opin. Immunol. 68, 64–71 (2021).
Dowling, L. R., Strazzari, M. R., Keely, S. & Kaiko, G. E. Enteric nervous system and intestinal epithelial regulation of the gut-brain axis. J. Allergy Clin. Immunol. 150, 513–522 (2022).
Vaes, N., Idris, M., Boesmans, W., Alves, M. M. & Melotte, V. Nerves in gastrointestinal cancer: from mechanism to modulations. Nat. Rev. Gastroenterol. Hepatol. 19, 768–784 (2022).
Holland, A. M., Bon-Frauches, A. C., Keszthelyi, D., Melotte, V. & Boesmans, W. The enteric nervous system in gastrointestinal disease etiology. Cell Mol. Life Sci. 78, 4713–4733 (2021).
Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science 374, 1087–1092 (2021).
Zhao, Q. et al. A multidimensional coding architecture of the vagal interoceptive system. Nature 603, 878–884 (2022).
Lagomarsino, V. N., Kostic, A. D. & Chiu, I. M. Mechanisms of microbial-neuronal interactions in pain and nociception. Neurobiol. Pain. 9, 100056 (2021).
Lai, N. Y. et al. Gut-innervating nociceptor neurons regulate Peyer’s patch microfold cells and SFB levels to mediate Salmonella host defense. Cell 180, 33–49 e22 (2020).
Lai, N. Y., Mills, K. & Chiu, I. M. Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence. J. Intern. Med. 282, 5–23 (2017).
Chang, H. Y., Mashimo, H. & Goyal, R. K. IV Current concepts of vagal efferent projections to the gut. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G357–G366 (2003).
Matzel, K. E., Stadelmaier, U., Hohenfellner, M. & Gall, F. P. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet 346, 1124–1127 (1995).
Willemze, R. A. et al. Loss of intestinal sympathetic innervation elicits an innate immune driven colitis. Mol. Med. 25, 1 (2019).
Muller, P. A. et al. Microbiota modulate sympathetic neurons via a gut–brain circuit. Nature 583, 441–446 (2020).
Schirmer, M. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167, 1125–1136.e1128 (2016).
Sato, Y. et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature 599, 458–464 (2021).
Sjogren, R. W. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 37, 1265–1282 (1994).
Roberts, C. G., Hummers, L. K., Ravich, W. J., Wigley, F. M. & Hutchins, G. M. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 55, 1697–1703 (2006).
D’Angelo, W. A., Fries, J. F., Masi, A. T. & Shulman, L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am. J. Med. 46, 428–440 (1969).
Howe, S. et al. Antimyenteric neuronal antibodies in scleroderma. J. Clin. Invest. 94, 761–770 (1994).
Singh, J. et al. Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function. Gastroenterology 143, 1308–1318 (2012).
Singh, J. et al. Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G1206–G1213 (2009).
Amaral, T. N., Peres, F. A., Lapa, A. T., Marques-Neto, J. F. & Appenzeller, S. Neurologic involvement in scleroderma: a systematic review. Semin. Arthritis Rheum. 43, 335–347 (2013).
Thoua, N. M., Schizas, A., Forbes, A., Denton, C. P. & Emmanuel, A. V. Internal anal sphincter atrophy in patients with systemic sclerosis. Rheumatology 50, 1596–1602 (2011).
Thoua, N. M., Abdel-Halim, M., Forbes, A., Denton, C. P. & Emmanuel, A. V. Fecal incontinence in systemic sclerosis is secondary to neuropathy. Am. J. Gastroenterol. 107, 597–603 (2012).
留言 (0)